Related Experiment Video

Updated: Jun 11, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

[Arsenic trioxide treatment in a patient with recurrent acute promyelocytic leukemia (APL)]

M L Moreno Tejero1, A Lassaletta Atienza, A García Salido

  • 1Hospital Universitario del Niño Jesús, Madrid, España. maluped2@hotmail.com

Anales De Pediatria (Barcelona, Spain : 2003)
|July 8, 2010
PubMed

Insights

Acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia, shows high recovery rates with all-trans-retinoic acid (ATRA) therapy. Arsenic trioxide is effective for relapsed APL, though pediatric use is limited.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML).
  • APL is characterized by M3 morphology and the specific t(15;17) chromosomal translocation.
  • This translocation results in the leukemogenic PML-RARalpha fusion gene.

Observation:

  • APL exhibits a unique therapeutic response to all-trans-retinoic acid (ATRA).
  • Patients with APL demonstrate higher recovery rates compared to other AML subtypes.
  • Arsenic trioxide has shown a high complete remission rate in relapsed APL cases.

Findings:

  • All-trans-retinoic acid (ATRA) is a key therapeutic agent for APL.
  • Arsenic trioxide is effective in managing APL relapses.
  • Limited clinical experience exists for arsenic trioxide in pediatric APL.

Implications:

  • ATRA therapy contributes to the favorable prognosis of APL.
  • Arsenic trioxide offers a viable treatment option for APL relapse.
  • Further research is needed to establish the safety and efficacy of arsenic trioxide in pediatric oncology.

Related Concept Videos

Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...